<unk> (injection) is a nitrogen mustard that is FDA approved for the treatment of and palliative treatment of Hodgkin’s disease (Stages III and IV), lymphosarcoma, chronic myelocytic or chronic lymphocytic leukemia, polycythemia vera, mycosis fungoides, and bronchogenic carcinoma; administered intrapleurally, intraperitoneally, or intrapericardially, is indicated for the palliative treatment of metastatic carcinoma resulting in effusion. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, depression, jaundice, alopecia, vertigo, tinnitus, diminished hearing, thrombosis and thrombophlebitis.
Mechlorethamine 
Ethchlorvynol
Loteprednol
Avacopan
Cloricromen
Cloprednol
Mebhydrolin
Dexbrompheniramine